Axel S. Merseburger
@amerseburger
Professor of Urology, Chairman Department of Urology, EiC "Aktuelle Urologie", Editor World Journal of Urology. Chairman EUSP, EAU-Board Member
ID: 5402392
http://www.urologie.uni-luebeck.de 22-04-2007 14:35:27
3,3K Tweet
4,4K Followers
983 Following
No rPFS benefit in ph III trial for Abemaciclib in combination with Abiraterone for treatment of mCRPC patients. OncoAlert UroToday.com Jacob Plieth investor.lilly.com/news-releases/…